| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Therapeuticsmd, Inc. (TXMD) has 4 insiders with recent SEC Form 4 filings, including 0 buys and 19 sells. TXMD is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 67.5K | $133.6K | - | |
| ? | 23.2K | $45.9K | - | |
| ? | 8.5K | $16.8K | - | |
| ? | 8.5K | $16.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 7, 2018 | Cartwright Daniel A | CFO | Sale+OE | 40,000 | $4.85 | $194,000.00 | -100% | |
| Oct 26, 2018 | Finizio Robert G | CEO | Sale+OE | 184,000 | $5.28 | $972,072.00 | -0.5% | |
| Oct 24, 2018 | Milligan John C.K. IV | President/ Secretary | Sale+OE | 250,000 | $5.35 | $1,337,500.00 | -7.8% | |
| Oct 19, 2018 | Bernick Brian | Director | Sale+OE | 182,800 | $5.56 | $1,016,368.00 | -1.4% | |
| Oct 12, 2018 | Finizio Robert G | CEO | Sale+OE | 184,000 | $5.55 | $1,020,832.00 | -0.5% | |
| Oct 10, 2018 | Milligan John C.K. IV | President/ Secretary | Sale+OE | 250,000 | $5.85 | $1,462,750.00 | -7.8% | |
| Oct 5, 2018 | Bernick Brian | Director | Sale+OE | 182,800 | $5.91 | $1,080,348.00 | -1.4% | |
| Sep 28, 2018 | Bernick Brian | Director | Sale+OE | 182,800 | $6.59 | $1,204,560.60 | -1.4% | |
| Sep 26, 2018 | Milligan John C.K. IV | President/ Secretary | Sale+OE | 250,000 | $6.78 | $1,694,250.00 | -7.8% | |
| Sep 21, 2018 | Finizio Robert G | CEO | Sale+OE | 184,000 | $6.63 | $1,219,000.00 | -0.5% |